Roche, Regeneron join forces to more than triple manufacturing of COVID-19 antibody cocktail

SourceFierce Pharma
Date Published08/19/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Regeneron
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
Domestically, the work will be done:In-house
Capital investment ($):450
City reshored to:Tarrytown
State(s) reshored to:NY
If relevant, work nearshored to:-
Product(s) reshoredREGN-COV2 antibody therapy
What domestic positive factors made reshoring more attractive?Government Incentives, Impact on domestic economy, covid-19
Government Incentive dollar amount:$540 million
Find Reshoring Articles